Simvastatin prevents isoproterenol-induced cardiac hypertrophy through modulation of the JAK/STAT pathway.

Saved in:

Bibliographic Details
Title:	Simvastatin prevents isoproterenol-induced cardiac hypertrophy through modulation of the JAK/STAT pathway.
Authors:	Al-Rasheed NM; Department of Pharmacology, Faculty of Pharmacy, King Saud University, Riyadh, Saudi Arabia., Al-Oteibi MM; Department of Pharmacology, Faculty of Pharmacy, King Saud University, Riyadh, Saudi Arabia., Al-Manee RZ; Department of Pharmacology, Faculty of Pharmacy, King Saud University, Riyadh, Saudi Arabia., Al-Shareef SA; Department of Pharmacology, Faculty of Pharmacy, King Saud University, Riyadh, Saudi Arabia., Al-Rasheed NM; Department of Pharmacology, Faculty of Pharmacy, King Saud University, Riyadh, Saudi Arabia., Hasan IH; Department of Pharmacology, Faculty of Pharmacy, King Saud University, Riyadh, Saudi Arabia., Mohamad RA; Department of Anatomy, College of Medicine, King Saud University, Riyadh, Saudi Arabia., Mahmoud AM; Physiology Division, Department of Zoology, Faculty of Science, Beni-Suef University, Egypt.
Source:	Drug design, development and therapy [Drug Des Devel Ther] 2015 Jun 23; Vol. 9, pp. 3217-29. Date of Electronic Publication: 2015 Jun 23 (Print Publication: 2015).
Publication Type:	Journal Article; Research Support, Non-U.S. Gov't
Journal Info:	Publisher: Dove Press Limited Country of Publication: New Zealand NLM ID: 101475745 Publication Model: eCollection Cited Medium: Internet ISSN: 1177-8881 (Electronic) Linking ISSN: 11778881 NLM ISO Abbreviation: Drug Des Devel Ther Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1177-8881
DOI:	10.2147/DDDT.S86431